ps2 jjba
Minor league pitchers Luis Moreno, Alejandro Crisostomo suspended after positive drug tests
LAS VEGAS — Players Era Festival organizers have done what so many other have tried — bet their fortunes in this city that a big payoff is coming. Such bet are usually bad ones, which is why so many massive casino-resorts have been built on Las Vegas Boulevard. But it doesn't mean the organizers are wrong. They're counting on the minimum of $1 million in guaranteed name, image and likeness money that will go to each of the eight teams competing in the neutral-site tournament that begins Tuesday will create a precedent for other such events. EverWonder Studios CEO Ian Orefice, who co-founded Players with former AND1 CEO Seth Berger, compared this event to last year's inaugural NBA In-Season Tournament that played its semifinals and final in Las Vegas by saying it "did really well to reinvigorate the fan base at the beginning of the year." "We're excited that we're able to really change the paradigm in college basketball on the economics," Orefice said. "But for us, it's about the long term. How do we use the momentum that is launching with the 2024 Players Era Festival and be the catalyst not to change one event, but to change college basketball for the future." Orefice and Berger didn't disclose financial details, but said the event will come close to breaking even this year and that revenue is in eight figures. Orefice said the bulk of the revenue will come from relationships with MGM, TNT Sports and Publicis Sport & Entertainment as well as sponsors that will be announced later. Both organizers said they are so bullish on the tournament's prospects that they already are planning ahead. Money made from this year's event, Orefice said, goes right back into the company. "We're really in this for the long haul," Orefice said. "So we're not looking at it on a one-year basis." Rick Giles is president of the Gazelle Group, which also operates several similar events, including the College Basketball Invitational. He was skeptical the financial numbers would work. Giles said in addition to more than $8 million going to the players, there were other expenses such as the guarantees to the teams. He said he didn't know if the tournament would make up the difference with ticket sales, broadcast rights and sponsorship money. The top bowl of the MGM Grand Garden Arena will be curtained off. "The math is highly challenging," Giles said. "Attendance and ticket revenues are not going to come anywhere close to covering that. They haven't announced any sponsors that I'm aware of. So it all sort of rests with their media deal with Turner and how much capital they want to commit to it to get these players paid." David Carter, a University of Southern California adjunct professor who also runs the Sports Business Group consultancy, said even if the Players isn't a financial success this year, the question is whether there will be enough interest to move forward. "If there is bandwidth for another tournament and if the TV or the streaming ratings are going to be there and people are going to want to attend and companies are going to want to sponsor, then, yeah, it's probably going to work," Carter said. "But it may take them time to gain that traction." Both founders said they initially were met with skepticism about putting together such an event, especially from teams they were interested in inviting. Houston was the first school to commit, first offering an oral pledge early in the year and then signing a contract in April. That created momentum for others to join, and including the No. 6 Cougars, half the field is ranked. "We have the relationships to operate a great event," Berger said. "We had to get coaches over those hurdles, and once they knew that we were real, schools got on board really quickly." The founders worked with the NCAA to make sure the tournament abided by that organization's rules, so players must appear at ancillary events in order to receive NIL money. Strict pay for play is not allowed, though there are incentives for performance. The champion, for example, will receive $1.5 million in NIL money. Now the pressure is on to pull off the event and not create the kind of headlines that can dog it for years to come. "I think everybody in the marketplace is watching what's going to happen (this) week and, more importantly, what happens afterwards," Giles said. "Do the players get paid on a timely basis? And if they do, that means that Turner or somebody has paid way more than the market dictates? And the question will be: Can that continue?" CREIGHTON: P oint guard Steven Ashworth likely won’t play in the No. 21 Bluejays’ game against San Diego State in the Players Era Festival in Las Vegas. Ashworth sprained his right ankle late in a loss to Nebraska on Friday and coach Greg McDermott said afterward he didn’t know how long he would be out. Be the first to know Get local news delivered to your inbox!AGNC Investment Corp. ( NASDAQ:AGNCM – Get Free Report ) announced a quarterly dividend on Wednesday, December 11th, NASDAQ Dividends reports. Investors of record on Wednesday, January 1st will be paid a dividend of 0.5904 per share on Wednesday, January 15th. This represents a $2.36 annualized dividend and a yield of 9.25%. The ex-dividend date of this dividend is Tuesday, December 31st. AGNC Investment has increased its dividend payment by an average of 72.4% per year over the last three years. AGNC Investment Stock Performance Shares of AGNC Investment stock opened at $25.52 on Friday. The stock’s 50 day simple moving average is $25.19 and its 200-day simple moving average is $25.19. AGNC Investment has a 1-year low of $23.51 and a 1-year high of $25.85. AGNC Investment Company Profile AGNC Investment Corp. provides private capital to housing market in the United States. It invests in residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by the United States government-sponsored enterprise or by the United States government agency. Further Reading Receive News & Ratings for AGNC Investment Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AGNC Investment and related companies with MarketBeat.com's FREE daily email newsletter .
US senator says mysterious drones spotted in New Jersey should be 'shot down, if necessary'House rejects Democratic efforts to force release of Matt Gaetz’s ethics report
What to know about Pam Bondi, Trump's new pick for attorney generalTEL AVIV, Israel (AP) — Israeli Prime Minister Benjamin Netanyahu underwent successful surgery Sunday to have his prostate removed, hospital officials said, a procedure that came as he manages multiple crises including the war in Gaza and his trial for alleged corruption . Netanyahu, who has had a series of health issues in recent years, has gone to great lengths to bolster a public image of himself as a healthy, energetic leader. During his trial this month, he boasted about working 18-hour days, accompanied by a cigar. But as Israel's longest-serving leader, such a grueling workload over a total of 17 years in power could take a toll on his well-being. Netanyahu, 75, is among older world leaders including U.S. President Joe Biden, 82 , President-elect Donald Trump, 78 , Brazil's President Luiz Inácio Lula da Silva , 79, and Pope Francis , 88, who have come under scrutiny for their age and health issues. Netanyahu's latest condition is common in older men, but the procedure has had some fallout. The judges overseeing his trial accepted a request from his lawyer on Sunday to call off three days of testimony scheduled this week. The lawyer, Amit Hadad, had argued that Netanyahu would be fully sedated for the procedure and hospitalized for “a number of days.” Dr. Ofer Gofrit, head of the urology department at Jerusalem's Hadassah Medical Center, said in a video statement late Sunday that the procedure had gone well and “there was no fear” of cancer or malignancy. “We only hope for the best,” he said. In a statement, Netanyahu thanked his doctors. His office said he was "fully alert" and was taken to an underground recovery unit fortified against potential missile attacks. Netanyahu was expected to remain in the hospital for several days of observation. Justice Minister Yariv Levin, a close ally, served as acting prime minister during the operation. With so much at stake, Netanyahu’s health in wartime is a concern for both Israelis and the wider world. As Israel’s leader, Netanyahu is at the center of major global events that are shifting the Middle East . With the dizzying pace of the past 14 months, being incapacitated for even a few hours can be risky. Netanyahu will be in the hospital at a time when international mediators are pushing Israel and Hamas to reach a ceasefire in Gaza and as fighting between Israel and Yemen’s Iran-backed Houthi rebels intensifies . Prostate issues are common and in many cases easily treatable. Still, the procedure puts a dent in Netanyahu’s image of vigor at a time when he would want to project strength more than ever, both to an Israeli audience navigating constant threats as well as to Israel’s enemies looking to expose its weaknesses. Netanyahu insists he is in excellent health. His office releases footage of him touring war zones in full protective gear flanked by military officers, or meeting with defense officials on windswept hilltops in youthful dark shades and puffer jackets. But that image was shattered last year when Netanyahu’s doctors revealed that he had a heart condition , a problem that he had apparently long known about but concealed from the public. A week after a fainting spell, Netanyahu was fitted with a pacemaker to control his heartbeat. Only then did staff at the Sheba Medical Center reveal that Netanyahu has for years experienced a condition that can cause irregular heartbeats. The revelation came as Netanyahu was dealing with massive anti-government protests. The news about a chronic heart problem stoked further anger and distrust during extreme political polarization in Israel. Last year, Netanyahu was rushed to the hospital for what doctors said likely was dehydration . He stayed overnight, prompting his weekly Cabinet meeting to be delayed. Earlier this year, Netanyahu underwent hernia surgery , during which he was under full anesthesia and unconscious. Levin served as acting prime minister during the operation. According to Netanyahu’s office, the Israeli leader was diagnosed with a urinary tract infection on Wednesday stemming from a benign enlargement of his prostate. The infection was treated successfully with antibiotics, but doctors said the surgery was needed in any case. Complications from prostate enlargement are common in men in their 70s and 80s, Dr. Shay Golan, head of the oncology urology service at Israel’s Rabin Medical Center, told Israeli Army Radio. Golan spoke in general terms and was not involved in Netanyahu’s care or treatment. He said an enlarged prostate can block proper emptying of the bladder, leading to a build-up of urine that can lead to an infection or other complications. After medicinal treatment, doctors can recommend a procedure to remove the prostate to prevent future blockages, Golan said. In Netanyahu’s case, because the prostate is not cancerous, Golan said doctors were likely performing an endoscopic surgery, carried out by inserting small instruments into a body cavity, rather than making surgical cuts in the abdomen to reach the prostate. The procedure lasts about an hour, Golan said, and recovery is quick. He said that aside from catheter use for one to three days after the procedure, patients can return to normal activity without significant limitations. AP correspondent Isaac Scharf contributed reporting.
Rico Carty, who won the 1970 NL batting title with the Atlanta Braves, dies at 85SRK says his fame-stardom are not solely his effortPressure on a veteran and senator shows what's next for those who oppose Trump
“There is no other political party in Namibia that has the legislative record, experience, maturity, and holding the government to account,” he said. Venaani spoke to the media in Windhoek ahead of Wednesday’s elections. He wants Namibians to vote for his party “that will be able to form its own government because it has experience”. Venaani said if young people want to change the status quo and their socio-economic circumstances, they need to vote for change. “The party that has MPs that went to prison because of youth unemployment, the party that has held the government to account, the party that is pushing the youth agenda, our representation, our diverse representation in parliament, no young person should walk away from PDM members of parliament that have done so well,” he said.
Two hundred dollars isn't a life-changing amount of money. Nevertheless, if handled properly, it can still generate a nice return on your investment. With that in mind, let's examine one smart way to invest $200. Exchange-traded funds, the best way to start Exchange-traded funds (ETFs) are one of the best ways to get started in the stock market. They are, in effect, a basket of stocks, grouped according to some characteristic. For example, some ETFs focus on a particular sector , like financials or energy companies. Others choose stocks based on their size. Still others focus on country of origin, buying shares of stocks based in Japan, Germany, Brazil, etc. Many different companies create and operate these ETFs, and the fees investors pay vary depending on the fund's strategy, its composition, and its costs. Let's examine a few different types of ETFs, and see which one stands out as the smartest choice right now. Types of ETFs There are thousands of ETFs , all created to serve a different purpose and audience. For example, the Vanguard Growth ETF ( VUG -1.43% ) is an ETF loaded with growth stocks . Its top holdings include tech giants Apple , Microsoft , and Amazon . Then there's the Vanguard Value ETF ( VTV -0.59% ) . This fund is focused on value stocks . Its top holdings include dividend-paying stocks Exxon Mobil , Procter & Gamble , and Coca-Cola . Finally, there's the iShares Top 20 U.S. Stocks ETF ( TOPT -1.45% ) . This fund narrows in on the 20 largest American stocks; its top holdings include Tesla , Apple , Microsoft , Nvidia , Alphabet , and Amazon . Each of these funds caters to a different audience, but none of them are my top choice for an investor with $200 to put to work. Instead, I would focus on a different ETF: the Invesco QQQ Series I Trust ( QQQ -1.33% ) . Here's why. Why the Invesco QQQ Series I ETF is a smart choice for so many investors This ETF is a smart choice for three reasons: It's designed to benefit from fast-growing tech companies. It boasts an excellent performance history. Its fees are low, making it a good fit for almost any portfolio. Let's start with the fund's strategy. This fund is designed to track the Nasdaq-100 index, which includes the 100 largest non-financial companies on the Nasdaq exchange. As a result, the fund's top holdings are similar to, but slightly different from the Vanguard Growth ETF. For example, this fund still counts Apple, Microsoft, and Nvidia among its top holdings, but it excludes financial stocks like Visa and Mastercard . Turning to performance, the Invesco fund has been one of the top-performing ETFs for a while. Over the last decade, for instance, the Invesco fund has generated a compound annual growth rate (CAGR) of 18.3%. That's far ahead of what the Vanguard Growth ETF (up 15.9%) produced, and it's almost double the return of the Vanguard Value ETF (up 10%). QQQ Total Return Level data by YCharts Finally, the fund offers a reasonable fee. Its expense ratio is only 0.2%. That means only $20 a year is paid in fees for an investment of $10,000. For a smaller amount, say $200, an investor will only surrender $0.40 in annual fees . Given the combination of low fees, excellent performance, and solid strategy, the Invesco ETF is the perfect choice for an investor looking to put $200 to work right now.
Rich countries' promise of $300 billion a year in climate finance brought fury at talks in Baku from poor nations that found it too paltry, but it also shows a shift in global political realities. The two-week marathon COP29 climate conference opened days after the decisive victory in the US presidential election of Donald Trump, a sceptic both of climate change and foreign aid. Javascript is required for you to be able to read premium content. Please enable it in your browser settings.ALPHARETTA, Ga. , Nov. 25, 2024 /PRNewswire/ -- Arclin, a leading material science company, officially launched its new brand on November 12, 2024 . This modern rebranding reflects the company's evolution as a material science provider with a focus on protective and mission-critical products and its expanded presence as a global leader across key market sectors. To better align its brand with its evolving vision, Arclin embarked on a year-long research, strategy, and creative development process. The initial months focused on gathering insights from internal stakeholders, existing customers, and industry experts to identify key strengths, value propositions, and areas for growth. "The research phase was pivotal in helping us sharpen our focus and align internally so that we could better represent our true value and potential to different internal and external audiences," said Mark Glaspey , Arclin's Chief Operating Officer. A key partner in this transformation has been Matchstic, a brand identity firm based in Atlanta, GA. Collaborating closely with the Arclin team, Matchstic helped transform the company's narrative from a chemical and applications company to that of a global leader in formulated technologies that are essential to meeting worldwide demand. As part of its overall rebranding effort, Arclin also worked with Whiteboard, a Chattanooga, TN , based company, to completely overhaul its website onto a more robust, easier-to-navigate platform that more clearly represents the depth and breadth of the company's offerings. Inspired by the Arclin out-of-the-box approach to thinking and innovating, the new brand symbol is a nod to a deconstructed cube. The shape of the panels implies movement and momentum that speaks to the company's continued innovation and commitment to bringing life-changing products to the world. "The selection of a vibrant orange as our primary color represents a bold departure from our previous brand," said Jana Wright , Arclin's Vice President of Brand & Marketing. "This change signals a confident transition, positioning Arclin as a leading material science company. Our new logo reflects our philosophy of technological precision and innovation." The stenciled wordmark visualizes the relationship between the seen and the unseen with intentional gaps inside the letterforms. This idea highlights the seemingly invisible science that is the backbone of Arclin products—technologies that are vital and found in essential protective products across numerous industries, enhancing our lives in ways that many people do not realize. "We've been around for many years, but never have we been able to fully articulate or capture what we do," stated Bradley Bolduc , Arclin's President and Chief Executive Officer. "It's a complex process, producing polymers and materials that touch so many products and areas of life. We've always taken a back seat in that story. But now is the time to change that, highlighting our transformation over the past five years, by making a bold change in how we present ourselves to our employees, customers and industry as a whole." About Arclin Arclin is a leading materials science company and manufacturer of polymer technologies, engineered products and specialized materials for the construction, agriculture, transportation infrastructure, weather & fire protection, pharmaceutical, nutrition, electronics, design, and other industries. Headquartered in Alpharetta, Georgia , Arclin has offices and manufacturing facilities throughout the U.S., Canada , and U.K. and manufactures for customers worldwide. For more information, visit www.arclin.com . Logo - https://mma.prnewswire.com/media/2222683/Arclin_Logo.jpg View original content: https://www.prnewswire.co.uk/news-releases/arclin-unveils-striking-new-brand-that-stands-out-in-the-material-science-industry-with-exacting-precision-and-a-bold-new-look-302315761.html
CORK, Ireland , Dec. 5, 2024 /PRNewswire/ -- The board of directors of Johnson Controls International plc JCI , the global leader in smart, healthy and sustainable buildings, has approved a regular quarterly dividend of $0.37 per share of common stock, payable on Jan. 17, 2025 , to shareholders of record at the close of business on Dec. 23, 2024 . Johnson Controls has paid a consecutive dividend since 1887. About Johnson Controls At Johnson Controls JCI , we transform the environments where people live, work, learn and play. As the global leader in smart, healthy and sustainable buildings, our mission is to reimagine the performance of buildings to serve people, places and the planet. Building on a proud history of nearly 140 years of innovation, we deliver the blueprint of the future for industries such as healthcare, schools, data centers, airports, stadiums, manufacturing and beyond through OpenBlue, our comprehensive digital offering. Today, with a global team of experts, Johnson Controls offers the world`s largest portfolio of building technology and software as well as service solutions from some of the most trusted names in the industry. Visit www.johnsoncontrols.com for more information and follow @Johnson Controls on social platforms. INVESTOR CONTACT: Jim Lucas Direct: +1 414.340.1752 Email: jim.lucas@jci.com MEDIA CONTACT: Danielle Canzanella Direct: +1 203.499.8297 Email: danielle.canzanella@jci.com View original content to download multimedia: https://www.prnewswire.com/news-releases/johnson-controls-announces-quarterly-dividend-302324312.html SOURCE Johnson Controls International plc © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.Feds suspend ACA marketplace access to companies accused of falsely promising ‘cash cards’
This Is What Whales Are Betting On Redfin
Samsara: Enterprise Customers Driving GrowthNEW YORK (AP) — Free agent pitchers Luis Gabriel Moreno and Alejandro Crisostomo were suspended for 80 games each by Major League Baseball on Friday following positive tests for performance-enhancing substances under the minor league drug program. Moreno tested positive for Nandrolone, and Crisostomo tested positive for Boldenone and Nandrolone, the commissioner’s office said. A 26-year-old right-hander, Moreno was released by the New York Mets’ Class A Brooklyn Cyclones on Tuesday. He was 5-1 with a 5.33 ERA in 12 relief appearances this season for Brooklyn after spending 2016-23 in the San Francisco Giants organization. Crisostomo, a 24-year-old right-hander, was released by Minnesota on Aug. 24 after going 0-1 with a 7.13 ERA this year with the Florida Complex League Twins. He signed with Boston in 2017, spent 2018 in the Dominican Summer League with the Red Sox, then signed with Minnesota and spent 2023 with the Twins DSL team. Nineteen players have been suspended this year for positive drug tests, including eight under the minor league program and nine under the new program for minor league players assigned outside the United States and Canada. Two players have been suspended this year under the major league drug program. Noelvi Marté , a 22-year-old infielder who is the Cincinnati Reds’ top prospect, missed the first 80 games following a positive test for boldenone. Toronto Blue Jays infielder Orelvis Martínez was suspended for 80 games on June 23 following a positive test for the performance-enhancing drug clomiphene, an announcement made two days after his major league debut . AP MLB: https://apnews.com/hub/mlb